Why India's generics program may have few private sector takers
This article was originally published in Scrip
Executive Summary
An Indian government tender for more than 280 drugs under its ambitious "Jan Aushadhi" cut-price medicines program is expected to generate limited interest from leading private players, if the early responses of a number of experts is anything to go by.